Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Cenexel Clinical Research, Inc. 401(K) Plan is a benefit plan reported by Cenexel Clinical Research, Inc. under EIN 83-1353724 and plan number 001. The latest loaded filing year is 2023. The filing reports 1,097 participants and $10,061,034 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $10,061,034
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $10,061,034
- Net assets (BOY)
- $7,667,788
Income & contributions
- Employer contributions
- $397,704
- Participant contributions
- $2,190,801
- Total contributions
- $2,825,578
- Total income / additions
- $4,242,429
Expenses & distributions
- Benefits paid
- $1,765,970
- Administrative expenses
- $80,098
- Total expenses
- $1,849,183
- Net increase / (decrease)
- $2,393,246